4//SEC Filing
Kalofonos Isabel 4
Accession 0001415889-23-007094
CIK 0000855654other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:32 PM ET
Size
8.1 KB
Accession
0001415889-23-007094
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Kalofonos Isabel
SVP & CHIEF COMMERCIAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2023-04-28+284,250→ 284,250 totalExercise: $5.39Exp: 2033-04-28→ Common Stock (284,250 underlying) - Award
Restricted Stock Unit
2023-04-28+47,375→ 47,375 totalExercise: $0.00→ Common Stock (47,375 underlying)
Footnotes (3)
- [F1]These options vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant, subject to continued service through each vesting date.
- [F2]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F3]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each of the first four anniversaries of the date of grant, subject to continued service through each vesting date.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001975163
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 4:32 PM ET
- Size
- 8.1 KB